UroGen Pharma (URGN) Shares Outstanding (2016 - 2026)

UroGen Pharma (URGN) Shares Outstanding (2016 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Outstanding (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	6,012.74 Bn
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	47.82 Bn
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	118.76 Bn
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	1.44 Bn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	254.10 Mn
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	104.00 Mn
7	Belite Bio	61.40 Bn	61.40 Bn	-	400.00 Mn
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	62.06 Mn
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	198.10 Mn
10	UroGen Pharma	2.05 Bn	1.91 Bn	46.82 Mn	50.18 Mn

Download Data